Q1 2025 Holdings
Filed 2025-05-15 | 68 holdings | $115.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $27.0K | 17,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $33.1K | 28,800 | 0.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $45.6K | 24,000 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $51.0K | 50,000 | 0.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $61.4K | 10,000 | 0.1% |
| 2Seventy BIO Inc(TSVT*) | COM | 901384107 | $76.6K | 15,500 | 0.1% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $104.7K | 27,985 | 0.1% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $130.4K | 16,500 | 0.1% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $130.7K | 22,000 | 0.1% |
| Direxion Daily Pharmaceutical & Medical Bull 3X SH(TECL) | DLY TECH BULL 3X | 25459W102 | $144.4K | 20,000 | 0.1% |
| Liquidia Corporation(LQDA) | COM | 53635D202 | $147.7K | 10,013 | 0.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $151.4K | 20,000 | 0.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $152.0K | 138,176 | 0.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $152.9K | 15,000 | 0.1% |
| Tela BIO Inc(TELA) | COM | 872381108 | $189.1K | 155,000 | 0.2% |
| Neuropace Inc(NPCE) | COM | 641288105 | $202.1K | 16,442 | 0.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $210.6K | 30,000 | 0.2% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $228.0K | 325,239 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $228.5K | 28,000 | 0.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $239.0K | 2,700 | 0.2% |
| Outset Medical Inc(OMGBP) | COM | 690145107 | $271.9K | 24,584 | 0.2% |
| Xencor Inc(XNCR) | COM | 98401F105 | $276.6K | 26,000 | 0.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $298.9K | 8,000 | 0.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $300.0K | 40,000 | 0.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $306.2K | 14,000 | 0.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $312.6K | 8,000 | 0.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $325.6K | 40,300 | 0.3% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $334.6K | 33,000 | 0.3% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $339.0K | 60,000 | 0.3% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $343.2K | 51,000 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $365.4K | 8,280 | 0.3% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $401.9K | 10,000 | 0.3% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $436.5K | 50,000 | 0.4% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $449.2K | 32,110 | 0.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $476.4K | 128,768 | 0.4% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $492.6K | 20,000 | 0.4% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $514.4K | 16,000 | 0.4% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $552.4K | 31,000 | 0.5% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $579.4K | 16,000 | 0.5% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $638.1K | 10,000 | 0.6% |
| Kiniksa Pharmaceuticals LTD | COM | G5269C101 | $666.4K | 30,006 | 0.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $699.8K | 6,000 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $704.6K | 21,000 | 0.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $773.2K | 67,002 | 0.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $940.2K | 88,697 | 0.8% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.1M | 310,930 | 1.0% |
| Treace Medical Concepts Inc(TMCI) | COM | 89455T109 | $1.4M | 164,947 | 1.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.4M | 210,005 | 1.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.7M | 50,000 | 1.4% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $1.8M | 88,404 | 1.5% |